Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Recombinant adeno-associated viral vector encoding a human micro-dystrophin gene under the control of a muscle specific promoter

EU orphan designation number: EU/3/16/1759   
Active ingredient: Recombinant adeno-associated viral vector encoding a human micro-dystrophin gene under the control of a muscle specific promoter
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: Pharma Gateway AB
Johanneslundsvägen 2, Hammarby, 194 61 Upplands Väsby, Stockholms Lan, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2016 Orphan designation EMA/OD/161/16 (2016)6751 of 14/10/2016
13/06/2017 Change of name and/or address of sponsor